Life ScienceCompany
Progenics Pharmaceuticals M&A Summary
Progenics Pharmaceuticals has acquired 1 company of its own.
Progenics Pharmaceuticals’ largest acquisition to date was in 2013, when it acquired Molecular Insight Pharmaceuticals Inc for $106M. Progenics Pharmaceuticals has acquired in 1 US state. The Company’s most targeted sectors include healthcare services (100%).
Progenics Pharmaceuticals Ownership
Who owns Progenics Pharmaceuticals?
Progenics Pharmaceuticals is owned by Lantheus Medical Imaging. It was acquired on October 2, 2019.
Progenics Pharmaceuticals Business Overview
Where is Progenics Pharmaceuticals headquartered?
Progenics Pharmaceuticals is headquartered in Tarrytown, New York.
What is Progenics Pharmaceuticals’ revenue?
Progenics Pharmaceuticals disclosed revenue of 16M USD for 2018 and 12M USD for 2017.
How many employees does Progenics Pharmaceuticals have?
Progenics Pharmaceuticals has 79 employees.
What sector is Progenics Pharmaceuticals in?
Progenics Pharmaceuticals is a life science company.
When was Progenics Pharmaceuticals founded?
Progenics Pharmaceuticals was founded in 1986.
M&A Summary
-
M&A Total Activity1
- M&A Buy Activity1
- Total Sectors Invested 1
- Total Countries Invested 1
Unlimited Searches
